A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV Vaccine

NCT05680454 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Human Papillomavirus Infection

Interventions

BIOLOGICAL: Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia Coli)
BIOLOGICAL: Recombinant nonavalent Human Papillomavirus (Types 6,11,16,18,31,33,45,52,58) Vaccine

Sponsor

Beijing Health Guard Biotechnology, Inc

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]